Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001567619-20-011337
Filing Date
2020-05-29
Accepted
2020-05-29 15:49:21
Documents
1
Effectiveness Date
2020-05-29
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10986
  Complete submission text file 0001567619-20-011337.txt   12043
Mailing Address 125 SUMMER STREET 16TH FLOOR BOSTON MA 02110
Business Address 125 SUMMER STREET 16TH FLOOR BOSTON MA 02110 857-204-8109
Atea Pharmaceuticals, Inc. (Filer) CIK: 0001593899 (see all company filings)

EIN.: 460574869 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-367951 | Film No.: 20927396